HomeNewsNeuroscience

  • Novel Biomarker for diagnosis of Alzheimer’s identified by researchers

    • September 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Drug Candidate identified for Parkinson’s Disease

    • September 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Phase 1b data for alzheimer’s disease treatment aducanumab announced

    • August 29, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New form of Multiple Sclerosis, MCMS, identified by investigators

    • August 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Multiple Sclerosis patients taking IV treatment mostly satisfied, claims study

    • August 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Increased Anxiety & Depression in Higher frequency Migraine patients, new research study says

    • August 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approved new ADHD drug JORNAY PM

    • August 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • TG Therapeutics completes Enrollment for Ublituximab in MS trial

    • August 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Botox shows efficacy in Multiple Sclerosis urinary symptoms

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Marijuana-Based Epilepsy Drug, Epidiolex priced at $32,500 for a Year

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more